HomeInsights52 Week High Stocks

Natco Pharma Ltd 52 Week High

Natco Pharma Ltd 52 Week High

stocks purchased

₹ 2.0 Cr

Volume Transacted

(Jan 15, 2025)

stocks purchased

16.6 K

Stocks Traded

(Jan 15, 2025)

Last Updated on: Jan 15, 2025

Image

Natco Pharma Ltd

NSE: NATCOPHARM

YEARHIGH

₹ 1638.35

Last updated on: Jan 15, 2025

Key Highlights

  • The 52 Week HIGH of Natco Pharma Ltd is ₹ 1638 as of 15 Jan 25 .

Company Fundamentals for Natco Pharma Ltd

No data available

Market Price of Natco Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Natco Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Jan 20251220.6
14 Jan 20251255.8
13 Jan 20251212.35
10 Jan 20251235.5
09 Jan 20251288.95
08 Jan 20251318.7
07 Jan 20251326.6
06 Jan 20251310.15
03 Jan 20251366.85
02 Jan 20251385.35

Asset Value vs Market Value of Natco Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Natco Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Natco Pharma Ltd

No data available

* All values are in crore

Natco Pharma Ltd News Hub

News

Natco Pharma Ltd gains for third straight session

Natco Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 1479...

Read more

19 Dec 2024 13:05

News

Natco Pharma Ltd soars 1.05%, Gains for third straight session

Natco Pharma Ltd is up for a third straight session in a row. The stock is quoting at Rs 1...

Read more

03 Dec 2024 13:06

News

Natco Pharma sells Telangana land for Rs 116 crore

The drug maker stated that since no business operations are carried out on the said land a...

Read more

28 Nov 2024 11:31

News

Natco Pharma submits ANDA with USFDA for Risdiplam for Oral solution

Natco Pharma today announced submission of Abbreviated New Drug Application (ANDA) with US...

Read more

21 Nov 2024 17:35

News

Natco Pharma submits ANDA with US FDA for Risdiplam

The ANDA is a generic version of Evrysdi (Risdiplam) for oral solution by Genentech Inc. R...

Read more

21 Nov 2024 15:00

News

Natco Pharma Ltd eases for fifth straight session

Natco Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 13...

Read more

13 Nov 2024 13:14

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Natco Pharma Ltd

What is the significance of Natco Pharma Ltd reaching its 52-week high?

Natco Pharma Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Natco Pharma Ltd 52-week high?

Investors monitor Natco Pharma Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Natco Pharma Ltd a good buy when it hits its 52-week high?

Whether Natco Pharma Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Natco Pharma Ltd fundamentals.

What should I consider before investing in Natco Pharma Ltd at its 52-week high?

Before investing in Natco Pharma Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Natco Pharma Ltd stock price continue to rise after reaching its 52-week high?

Natco Pharma Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions